Aclaris Therapeutics (0H8T.LSE) Q4 2024 Earnings

Nov 6Confirmed
Q2 2024
Q3 2024
Q4 2024
-0.29
-0.19
-0.1
-0.01

Details

Expected EPS
-0.005714
Actual EPS
-0.11
Surprise EPS
-0.1
Surprise Percent
-1,825.1%

Description

⁨Aclaris Therapeutics⁩ (⁦0H8T.LSE⁩) has reported earnings of ⁦-0.11⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts